Evidence map›Paper›PMID 33995557›Full record

ArticleUltrasound (Leeds, England)2021

Quantitative colour Doppler and greyscale ultrasound for evaluating prostate cancer.

Khalid Ashi, Brooke Kirkham, Anil Chauhan, Susan M Schultz, Bonnie J Brake, Chandra M Sehgal

Open access · greenAbstract read
In one paragraph

Article in Ultrasound (Leeds, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Khalid AshiRadiology, University of Pennsylvania, Philadelphia, USA.
Brooke KirkhamRadiology, University of Pennsylvania, Philadelphia, USA.
Anil ChauhanUniversity of Minnesota, Minneapolis, USA.
Susan M SchultzRadiology, University of Pennsylvania, Philadelphia, USA.
Bonnie J BrakeHospital of the University of Pennsylvania, Philadelphia, USA.
Chandra M SehgalRadiology, University of Pennsylvania, Philadelphia, USA.ORCID https://orcid.org/0000-0002-8811-1930
University of Pennsylvania · USHospital of the University of Pennsylvania · USUniversity of Minnesota · US

Funding

Antivascular ultrasound therapy of primary liver neoplasiaR01CA204446 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SEHGAL, CHANDRA M · 2017 to 2021
$2.0M
Tunable microbubbles for antivascular ultrasoundR01EB022612 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI SEHGAL, CHANDRA M · 2016 to 2019
$1.6M
NCI NIH HHS R01 CA204446NIBIB NIH HHS R01 EB022612
6 · The paper itself

Abstract

introductionAlthough transrectal ultrasound is routinely performed for imaging prostate lesions, colour Doppler imaging visualizing vascularity is not commonly used for diagnosis. The goal of this study was to measure vascular and echogenic differences between malignant and benign lesions of the prostate by quantitative colour Doppler and greyscale transrectal ultrasound.

methodsGreyscale and colour Doppler ultrasound images of the prostate were acquired in 16 subjects with biopsy-proven malignant or benign lesions. Echogenicity and microvascular flow velocity of each lesion were measured by quantitative image analysis. Flow velocity was measured over several cardiac cycles and the velocity-time waveform was used to determine microvascular pulsatility index and microvascular resistivity index. The Wilcoxon rank sum test was used to compare the malignant and benign groups.

resultsMedian microvascular flow velocity of the malignant lesions was 1.25 cm/s compared to 0.36 cm/s for the benign lesions. Median pulsatility and resistive indices of the malignant lesions were 1.55 and 0.68, respectively versus 6.38 and 1.0 for the benign lesions. Malignant lesions were more hypoechoic relative to the surrounding tissue, with median echogenicity of 0.24 compared to 0.76 for the benign lesions. The differences between the malignant and benign groups for each measurement were significant (p < 0.01).

conclusionMarked differences were observed in flow velocity, microvascular pulsatility, microvascular resistance, and echogenicity of prostate cancer measured with quantitative colour Doppler and greyscale ultrasound imaging. Vascular differences measured together with echogenicity have the combined potential to characterize malignant and benign prostate lesions.

Indexed as

colour Dopplerprostate cancerquantitativeUltrasound

Identifiers

PMID33995557
PMCPMC8083141
OpenAlexW3084385756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.